ReviewMicromachines2026
Microrobots for Precision Diagnosis and Treatment in the Digestive System: A Review of Actuation Mechanisms, Structural Design, Preclinical and Translational Applications.
Review in Micromachines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Because lesions associated with digestive system diseases are often deeply seated, embedded within complex luminal milieus, and protected by substantial local delivery barriers, conventional diagnostic and therapeutic modalities remain constrained in their targeting capability, minimal invasiveness, and precision. Microrobots, leveraging micro-scale motion, active navigation, programmable controllability, and theranostic integration, open a new avenue for the precise diagnosis and treatment of digestive system diseases. Here, we review the major actuation modalities and structural designs of microrobots and discuss recent advances in their use across the gastrointestinal and hepatopancreatobiliary systems, focusing on targeted drug delivery, biospecimen harvesting, lesion detection, and interventional treatment. We further discuss the major obstacles to progress in this field, including robust operation in complex in vivo settings, real-time imaging and closed-loop feedback control, biosafety, degradability, and eventual clinical implementation. With continued advances in high-performance materials, multimodal actuation, intelligent control, and convergence with endoscopic and medical imaging technologies, microrobots are poised to accelerate the transition of digestive disease care toward precision, intelligence, and minimally invasive intervention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.